Julho'18
Review article: predictors
of response to vedolizumab and ustekinumab in inflammatory bowel disease.
A. Barre, J.-F. Colombel, R. Ungaro
Review article: predictors
of response to vedolizumab and ustekinumab in inflammatory bowel disease.
A. Barre, J.-F. Colombel, R. Ungaro